Navigation Links
Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
Date:11/3/2008

CORAL GABLES, Fla., Nov. 3 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) a biopharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that Patrick J. McEnany, Chief Executive Officer, will be presenting an overview of the Company at the Rodman & Renshaw 10th Annual Global Investment Conference on Tuesday, November 11, 2008 at 10:45 am Eastern Time at the New York Palace Hotel in New York City.

Interested parties can access a live or archived web cast of the presentation at: http://www.wsw.com/webcast/rrshq14/cprx . The presentation will be archived for 90 days.

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for Brookhaven's patent portfolio in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted "Fast Track" status by the U.S. Food & Drug Administration (FDA) for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Using catalysts to stamp nanopatterns without ink
2. Experiments reveal unexpected activity of fuel cell catalysts
3. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
4. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
5. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
6. Controlling the size of nanoclusters: First step in making new catalysts
7. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
8. NIST and partners identify tiny gold clusters as top-notch catalysts
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Patrick Kennedy Joins with State Biotech Leaders ... in Research and Development while Boosting Rhode ... ,, PROVIDENCE, R.I., Dec. 14 /PRNewswire-USNewswire/ ... leaders in research, medicine and biotechnology gathered ... to discuss the importance of medical innovation ...
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... the atrial fibrillation drug market will increase more ... $6.1 billion in 2018 in the United States, ... Japan. ,, The new Pharmacor report entitled ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
(Date:12/11/2009)... -- Marrone Bio Innovations (MBI) today announces 2 ... Chris Hildreth joined MBI as Senior Vice President ... all commercial aspects of the company, including sales, ... (Ray) Lam joined MBI as Vice President of ... in scaling its broad pipeline of products to ...
Breaking Biology Technology:Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... Honoring Mental Health Programs Supported by a Grant from Otsuka ... America Pharmaceutical, ... has named three nonprofit organizations and one individual,as the recipients of ... were presented at the 2008 APF Annual Benefit in,Washington, D.C. Each ...
... 6 Cepheid (Nasdaq:,CPHD) announced today that the Company will present ... Growth Stock Conference on May 13 at 12:15 p.m. EDT ... -- The Bank of America Healthcare Conference on May 14 at ... Hotel in Las Vegas, John Bishop, Chief Executive Officer, and ...
... NeoGenomics, Inc. (OTC,Bulletin Board: NGNM) announced today that it plans ... 7, 2008., The Company has scheduled a webcast ... 7, 2008, at 11:00 AM EDT. Interested investors should,dial ... prior to the call. A replay of the conference ...
Other Biology Technology:American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference 2NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008 2
(Date:12/11/2009)... common knowledge that smoking is a health risk but ... than adults? In an evaluation for Faculty of 1000 ... prone to substance abuse. , Grunberg describes the study, ... journal, as "fascinating" and suggests it "may have implications ... drug abuse". , Nicotine increases the level of dopamine ...
(Date:12/11/2009)... hake, lumpsucker and salmon is the best dietary source of ... at the University of Almera (UAL). The scientists analysed the ... of these contained high levels of these fatty acids, which ... had been no precise understanding of the nutritional potential of ... from the UAL has now shown that this is one ...
(Date:12/11/2009)... 190 nations are gathered at the two-week UN ... 150 distinguished guests attended an ESA-hosted side event ... Climate Variables,. , During the event, speakers from ... satellites play in providing systematic global climate observations. ... and for managing mitigation and adaptation strategies. ,The ...
Breaking Biology News(10 mins):Roe of marine animals is best natural source of omega-3 2Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age Related Macular Degeneration 60195 1NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age Related Macular Degeneration 60195 2NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age Related Macular Degeneration 60195 3AMICAS Schedules Third Quarter 2009 Earnings Results Conference Call 60190 1AMICAS Schedules Third Quarter 2009 Earnings Results Conference Call 60190 2Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 1Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 2Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 3Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 4Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 5Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin Associated Periodic Syndromes 28CAPS 29 14621 6
... 30 -- Two groups of researchers, one in the ... development of new optical techniques for visualizing the invisible ... results are the first to showcase the Optical Society,s ... to submit a manuscript that includes large three-dimensional data ...
... The world,s rarest big cat is alive and well. ... from the Wildlife Conservation Society (WCS) who captured and released ... capture was made in Primorsky Krai along the Russian-Chinese border ... Academy of Sciences Institute of Biology and Soils (IBS). ...
... This release is available in German . , Research ... But many women are put off using contraceptive pills ... adverse effects. Their concern may be narrowing their contraceptive ... for Quality and Efficiency in Health Care (IQWiG). Different ...
Other Biology News:OSA's ISP launches with research on breathing disorders and congenital heart defects 2OSA's ISP launches with research on breathing disorders and congenital heart defects 3OSA's ISP launches with research on breathing disorders and congenital heart defects 4World's rarest big cat gets a check-up 2World's rarest big cat gets a check-up 3Research shows that the pill does not deserve its reputation for causing weight gain 2
... uptake of long double stranded RNA (dsRNA) ... in a diverse group of organisms as ... interference leads to the inhibition of protein ... the target messenger RNA (mRNA). Attempts to ...
... jetSI-ENDO is an easy-to-use siRNA transfection reagent ... endogenous genes in a variety of cell ... with an optimized, straightforward protocol. High levels ... obtained following transfection of 20 to 100 ...
... stranded RNA (dsRNA) has been shown to ... of organisms as well as insect cells ... inhibition of protein expression by utilizing sequence-specific, ... (mRNA). Attempts to induce RNA interference using ...
... distinguish collagen from muscle in tissue specimens ... stain is often used to differentiate between ... an increase in collagenous tissue. With the ... red, collagen - blue, fibrin - pink, ...
Biology Products: